APO Research, Inc.

APO RESEARCH · REPORT

Antithyroid Drug

Selected research

Industry Growth & Trends

Global Antithyroid Drug Industry Growth and Trends Forecast to 2032

Market perspective

The global Antithyroid Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antithyroid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antithyroid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antithyroid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antithyroid Drug include Avet Pharmaceuticals Inc., Par Pharmaceutical, Zhaohui Pharmaceutical, Hemony Pharmaceutical, Pfizer Inc, Merck KGaA, Teva Pharmaceuticals and YanJing Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antithyroid Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antithyroid Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antithyroid Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antithyroid Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antithyroid Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antithyroid Drug Market by Company

Avet Pharmaceuticals Inc.

Par Pharmaceutical

Zhaohui Pharmaceutical

Hemony Pharmaceutical

Pfizer Inc

Merck KGaA

Teva Pharmaceuticals

YanJing Pharm

Antithyroid Drug Segment by Type

Methimazole

Propylthiouracil

Other

Antithyroid Drug Segment by Application

Hospital

Pharmacy

Other

Antithyroid Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antithyroid Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antithyroid Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Methimazole Table 2. Major Company of Propylthiouracil Table 3. Major Company of Other Table 4. Global Antithyroid Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Antithyroid Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antithyroid Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antithyroid Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Antithyroid Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Antithyroid Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Antithyroid Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antithyroid Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antithyroid Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Antithyroid Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Antithyroid Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Antithyroid Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Antithyroid Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Antithyroid Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Antithyroid Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Antithyroid Drug Industry Trends Table 26. Antithyroid Drug Industry Drivers Table 27. Antithyroid Drug Industry Opportunities and Challenges Table 28. Antithyroid Drug Industry Restraints Table 29. Global Antithyroid Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antithyroid Drug Revenue Market Share by Company (2021-2026) Table 31. Global Antithyroid Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Antithyroid Drug Sales Share by Company (2021-2026) Table 33. Global Antithyroid Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Antithyroid Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antithyroid Drug Major Company Production Sites and Headquarters Table 36. Global Antithyroid Drug Company, Product Type & Application Table 37. Global Antithyroid Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antithyroid Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antithyroid Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antithyroid Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Antithyroid Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antithyroid Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antithyroid Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Antithyroid Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Antithyroid Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antithyroid Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antithyroid Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Antithyroid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Antithyroid Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Antithyroid Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antithyroid Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antithyroid Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Antithyroid Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Antithyroid Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Antithyroid Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antithyroid Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antithyroid Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Antithyroid Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Antithyroid Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Antithyroid Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Antithyroid Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Antithyroid Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Antithyroid Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Avet Pharmaceuticals Inc. Company Information Table 73. Avet Pharmaceuticals Inc. Business Overview Table 74. Avet Pharmaceuticals Inc. Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio Table 76. Avet Pharmaceuticals Inc. Recent Development Table 77. Par Pharmaceutical Company Information Table 78. Par Pharmaceutical Business Overview Table 79. Par Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Par Pharmaceutical Antithyroid Drug Product Portfolio Table 81. Par Pharmaceutical Recent Development Table 82. Zhaohui Pharmaceutical Company Information Table 83. Zhaohui Pharmaceutical Business Overview Table 84. Zhaohui Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio Table 86. Zhaohui Pharmaceutical Recent Development Table 87. Hemony Pharmaceutical Company Information Table 88. Hemony Pharmaceutical Business Overview Table 89. Hemony Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hemony Pharmaceutical Antithyroid Drug Product Portfolio Table 91. Hemony Pharmaceutical Recent Development Table 92. Pfizer Inc Company Information Table 93. Pfizer Inc Business Overview Table 94. Pfizer Inc Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Inc Antithyroid Drug Product Portfolio Table 96. Pfizer Inc Recent Development Table 97. Merck KGaA Company Information Table 98. Merck KGaA Business Overview Table 99. Merck KGaA Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Merck KGaA Antithyroid Drug Product Portfolio Table 101. Merck KGaA Recent Development Table 102. Teva Pharmaceuticals Company Information Table 103. Teva Pharmaceuticals Business Overview Table 104. Teva Pharmaceuticals Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Pharmaceuticals Antithyroid Drug Product Portfolio Table 106. Teva Pharmaceuticals Recent Development Table 107. YanJing Pharm Company Information Table 108. YanJing Pharm Business Overview Table 109. YanJing Pharm Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. YanJing Pharm Antithyroid Drug Product Portfolio Table 111. YanJing Pharm Recent Development Table 112. North America Antithyroid Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 114. North America Antithyroid Drug Sales Market Share by Country (2021-2026) Table 115. North America Antithyroid Drug Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Antithyroid Drug Sales Market Share Forecast by Country (2027-2032) Table 117. North America Antithyroid Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Antithyroid Drug Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Antithyroid Drug Market Share by Country (2021-2026) Table 120. North America Antithyroid Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Antithyroid Drug Market Share Forecast by Country (2027-2032) Table 122. Europe Antithyroid Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 124. Europe Antithyroid Drug Sales Market Share by Country (2021-2026) Table 125. Europe Antithyroid Drug Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Antithyroid Drug Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Antithyroid Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Antithyroid Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Antithyroid Drug Market Share by Country (2021-2026) Table 130. Europe Antithyroid Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Antithyroid Drug Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Antithyroid Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Antithyroid Drug Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Antithyroid Drug Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Antithyroid Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Antithyroid Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Antithyroid Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Antithyroid Drug Market Share by Country (2021-2026) Table 140. Asia-Pacific Antithyroid Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Antithyroid Drug Market Share Forecast by Country (2027-2032) Table 142. Latin America Antithyroid Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 144. Latin America Antithyroid Drug Sales Market Share by Country (2021-2026) Table 145. Latin America Antithyroid Drug Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Antithyroid Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Antithyroid Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Antithyroid Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Antithyroid Drug Market Share by Country (2021-2026) Table 150. Latin America Antithyroid Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Antithyroid Drug Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Antithyroid Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Antithyroid Drug Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Antithyroid Drug Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Antithyroid Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Antithyroid Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Antithyroid Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Antithyroid Drug Market Share by Country (2021-2026) Table 160. Middle East and Africa Antithyroid Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Antithyroid Drug Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Antithyroid Drug Distributors List Table 165. Antithyroid Drug Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Antithyroid Drug Image Figure 2. Global Antithyroid Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithyroid Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Antithyroid Drug Sales (2021-2032) & (K Units) Figure 5. Methimazole Image Figure 6. Global Methimazole Sales YoY Growth (2021-2032) & (K Units) Figure 7. Propylthiouracil Image Figure 8. Global Propylthiouracil Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Antithyroid Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antithyroid Drug Market Share by Type 2025 VS 2032 Figure 13. North America Antithyroid Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Antithyroid Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Antithyroid Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antithyroid Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antithyroid Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antithyroid Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antithyroid Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antithyroid Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antithyroid Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antithyroid Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antithyroid Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Antithyroid Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antithyroid Drug Market Share by Application 2025 VS 2032 Figure 33. North America Antithyroid Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Antithyroid Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Antithyroid Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antithyroid Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antithyroid Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antithyroid Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antithyroid Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antithyroid Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antithyroid Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antithyroid Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Antithyroid Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Antithyroid Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antithyroid Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antithyroid Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Antithyroid Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antithyroid Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antithyroid Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Antithyroid Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antithyroid Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antithyroid Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Antithyroid Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antithyroid Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antithyroid Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Antithyroid Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antithyroid Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antithyroid Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antithyroid Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Methimazole
  • Propylthiouracil
  • Other
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Avet Pharmaceuticals Inc.
  • Par Pharmaceutical
  • Zhaohui Pharmaceutical
  • Hemony Pharmaceutical
  • Pfizer Inc
  • Merck KGaA
  • Teva Pharmaceuticals
  • YanJing Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antithyroid Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antithyroid Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antithyroid Drug Market by Type
  6. 1.3.1 Methimazole
  7. 1.3.2 Propylthiouracil
  8. 1.3.3 Other
  9. 1.4 Global Antithyroid Drug Market Size by Type
  10. 1.4.1 Global Antithyroid Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antithyroid Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antithyroid Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antithyroid Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antithyroid Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antithyroid Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antithyroid Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antithyroid Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antithyroid Drug Industry Trends
  2. 2.2 Antithyroid Drug Industry Drivers
  3. 2.3 Antithyroid Drug Industry Opportunities and Challenges
  4. 2.4 Antithyroid Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antithyroid Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Antithyroid Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Antithyroid Drug Price (2021-2026)
  4. 3.4 Global Antithyroid Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antithyroid Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Antithyroid Drug Company, Product Type & Application
  7. 3.7 Global Antithyroid Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antithyroid Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antithyroid Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antithyroid Drug Tier 1, Tier 2, and Tier 3
4 Antithyroid Drug Regional Status and Outlook
  1. 4.1 Global Antithyroid Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antithyroid Drug Historic Market Size by Region
  3. 4.2.1 Global Antithyroid Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antithyroid Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antithyroid Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antithyroid Drug Forecasted Market Size by Region
  7. 4.3.1 Global Antithyroid Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antithyroid Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antithyroid Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antithyroid Drug by Application
  1. 5.1 Antithyroid Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Antithyroid Drug Market Size by Application
  6. 5.2.1 Global Antithyroid Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antithyroid Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antithyroid Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antithyroid Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antithyroid Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antithyroid Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antithyroid Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antithyroid Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Avet Pharmaceuticals Inc.
  2. 6.1.1 Avet Pharmaceuticals Inc. Company Information
  3. 6.1.2 Avet Pharmaceuticals Inc. Business Overview
  4. 6.1.3 Avet Pharmaceuticals Inc. Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio
  6. 6.1.5 Avet Pharmaceuticals Inc. Recent Developments
  7. 6.2 Par Pharmaceutical
  8. 6.2.1 Par Pharmaceutical Company Information
  9. 6.2.2 Par Pharmaceutical Business Overview
  10. 6.2.3 Par Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Par Pharmaceutical Antithyroid Drug Product Portfolio
  12. 6.2.5 Par Pharmaceutical Recent Developments
  13. 6.3 Zhaohui Pharmaceutical
  14. 6.3.1 Zhaohui Pharmaceutical Company Information
  15. 6.3.2 Zhaohui Pharmaceutical Business Overview
  16. 6.3.3 Zhaohui Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio
  18. 6.3.5 Zhaohui Pharmaceutical Recent Developments
  19. 6.4 Hemony Pharmaceutical
  20. 6.4.1 Hemony Pharmaceutical Company Information
  21. 6.4.2 Hemony Pharmaceutical Business Overview
  22. 6.4.3 Hemony Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hemony Pharmaceutical Antithyroid Drug Product Portfolio
  24. 6.4.5 Hemony Pharmaceutical Recent Developments
  25. 6.5 Pfizer Inc
  26. 6.5.1 Pfizer Inc Company Information
  27. 6.5.2 Pfizer Inc Business Overview
  28. 6.5.3 Pfizer Inc Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Inc Antithyroid Drug Product Portfolio
  30. 6.5.5 Pfizer Inc Recent Developments
  31. 6.6 Merck KGaA
  32. 6.6.1 Merck KGaA Company Information
  33. 6.6.2 Merck KGaA Business Overview
  34. 6.6.3 Merck KGaA Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck KGaA Antithyroid Drug Product Portfolio
  36. 6.6.5 Merck KGaA Recent Developments
  37. 6.7 Teva Pharmaceuticals
  38. 6.7.1 Teva Pharmaceuticals Company Information
  39. 6.7.2 Teva Pharmaceuticals Business Overview
  40. 6.7.3 Teva Pharmaceuticals Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceuticals Antithyroid Drug Product Portfolio
  42. 6.7.5 Teva Pharmaceuticals Recent Developments
  43. 6.8 YanJing Pharm
  44. 6.8.1 YanJing Pharm Company Information
  45. 6.8.2 YanJing Pharm Business Overview
  46. 6.8.3 YanJing Pharm Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 YanJing Pharm Antithyroid Drug Product Portfolio
  48. 6.8.5 YanJing Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Antithyroid Drug Sales by Country
  2. 7.1.1 North America Antithyroid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antithyroid Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Antithyroid Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antithyroid Drug Market Size by Country
  6. 7.2.1 North America Antithyroid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antithyroid Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Antithyroid Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antithyroid Drug Sales by Country
  2. 8.1.1 Europe Antithyroid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antithyroid Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Antithyroid Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antithyroid Drug Market Size by Country
  6. 8.2.1 Europe Antithyroid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antithyroid Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antithyroid Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antithyroid Drug Sales by Country
  2. 9.1.1 Asia-Pacific Antithyroid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antithyroid Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antithyroid Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antithyroid Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Antithyroid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antithyroid Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antithyroid Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antithyroid Drug Sales by Country
  2. 10.1.1 South America Antithyroid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antithyroid Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Antithyroid Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antithyroid Drug Market Size by Country
  6. 10.2.1 South America Antithyroid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antithyroid Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Antithyroid Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antithyroid Drug Sales by Country
  2. 11.1.1 Middle East and Africa Antithyroid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antithyroid Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antithyroid Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antithyroid Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Antithyroid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antithyroid Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antithyroid Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antithyroid Drug Value Chain Analysis
  2. 12.1.1 Antithyroid Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antithyroid Drug Production Mode & Process
  7. 12.2 Antithyroid Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antithyroid Drug Distributors
  10. 12.2.3 Antithyroid Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.